This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Bloodhound cells target cancer in antibody hope
Immunoglobulin monoclonal antibodies are being funded heavily in a push to use engineered cells to seek out pathogens and trigger immune attack. Despite optimism, experts caution they are not a universal cure and require ongoing treatment. progress includes trials for breast cancer hepatitis and lymphoma with several candidates moving toward FDA review.
MENTIONED IN THIS ARTICLE
San Francisco
David Goldenberg
Food and Drug Administration
Goldenberg
Biotechnology Industry Organization
William Rastetter
Idec Pharmaceuticals Corp